| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |